|
Our specialty is the combination of many years working as a “hired gun” sales force. We have been privileged to represent Fortune 500 Companies, many of which are listed on NASDAQ and the NYSE.
Over the years, we have accumulated extensive knowledge in the device areas of abdominopelvic surgery, female pelvic health, laparoscopic, bariatric and cardiothoracic disciplines.
We have brought new products to the marketplace; grew the market until their eventual disposition to the likes of United States Surgical Corporation or J&J. We are trailblazers and understand the layers of challenges to succeed in medical device sales.
We also know that there are tremendous technologies abroad. We have the ability to assist in setting up a “US presence”, handle all legal paperwork, financials, regulatory and more.
Contact us at info@MDRLLC.net for additional information and testimonials.
|
 |
 |
|
 |
| Fri, 24 May 2013 01:00:00 PDT |
|
Inexpensive, Accurate Way To Detect Prostate Cancer Could Facilitate Commercially Available, At-Home Urine Tests
More..
|
|
|
Bioresorbable Drug-Eluting Scaffolds Emerging As The Dominant Device Of The Future For Percutaneous Coronary Interventions
More..
|
|
|
Mass Spectrometers Offer Insight Into The Dazzling Impact Of Insulin In Cells
More..
|
|
|
Results Of The BIOFLOW-II Substudy: Biodegradable Stent Proves Non-Inferior To Drug-Eluting Stent
More..
|
|
|
1-Year TAVI Outcomes Post-Approval Showed A Large Treatment Effect In Terms Of Symptom Relief And Improved Quality Of Life
More..
|
|
|
|
|
|